(Q38974088)

8 September 2017

title

A recombinant virus assay using full-length envelope sequences to detect changes in HIV-1 co-receptor usage (English)

1 reference

8 September 2017

author

Hans-Georg Kräusslich

5

object named as

Kräusslich HG

1 reference

8 September 2017

Dittmar MT

1

1 reference

8 September 2017

Eichler S

2

1 reference

8 September 2017

Reinberger S

3

1 reference

8 September 2017

Henning L

4

1 reference

8 September 2017

publication date

1 December 2001

1 reference

8 September 2017

1 reference

8 September 2017

volume

23

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

281-290

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1012569206007

8 September 2017

exact match

0 references

cites work

Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants

1 reference

12 December 2020

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

12 December 2020

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

12 December 2020

HIV entry and its inhibition

1 reference

12 December 2020

Chemokines and viruses: the dearest enemies

1 reference

12 December 2020

A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism.

1 reference

12 December 2020

V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies

1 reference

12 December 2020

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

12 December 2020

Coreceptors--Implications for HIV Pathogenesis and Therapy

1 reference

12 December 2020

Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay

1 reference

12 December 2020

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1 reference

12 December 2020

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

12 December 2020

Advances in the medical management of patients with HIV-1 infection: an overview

1 reference

12 December 2020

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

12 December 2020

Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.

1 reference

12 December 2020

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

12 December 2020

Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1).

1 reference

12 December 2020

Incidence and impact of resistance against approved antiretroviral drugs

1 reference

12 December 2020

Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

1 reference

12 December 2020

Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5.

1 reference

12 December 2020

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

1 reference

12 December 2020

Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

1 reference

12 December 2020

An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity

1 reference

12 December 2020

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

1 reference

12 December 2020

Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.

1 reference

12 December 2020

Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket

1 reference

12 December 2020

Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay

1 reference

12 December 2020

Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage

1 reference

12 December 2020

Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1.

1 reference

12 December 2020

HIV-1 entry inhibitors in the side pocket

1 reference

12 December 2020

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

1 reference

12 December 2020

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

12 December 2020

Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance

1 reference

12 December 2020

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study

1 reference

12 December 2020

Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target

1 reference

12 December 2020

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

1 reference

12 December 2020

Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus

1 reference

12 December 2020

The U3 promoter region of the acutely lethal simian immunodeficiency virus clone smmPBj1.9 confers related biological activity on the apathogenic clone agm3mc

1 reference

12 December 2020

Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.

1 reference

12 December 2020

Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients

1 reference

12 December 2020

Coreceptor requirements of primary HIV type 1 group O isolates from Cameroon

1 reference

12 December 2020

The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion

1 reference

12 December 2020

Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage.

1 reference

12 December 2020

Electric shock-mediated transfection of cells. Characterization and optimization of electrical parameters

1 reference

12 December 2020

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

12 December 2020

Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity

1 reference

12 December 2020

Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates.

1 reference

12 December 2020

Spoilt for choice of co-receptors

1 reference

12 December 2020

Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies.

1 reference

12 December 2020

Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1012569206007

1 reference

Dimensions Publication ID

8 September 2017

1012166460

0 references

1 reference